Cite
HARVARD Citation
LoRusso, P. et al. (n.d.). Phase 1 Study of first-in-class dUTPase inhibitor, TAS-114 in combination with capecitabine in patients with advanced solid tumors. European journal of cancer. pp. S119-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
LoRusso, P. et al. (n.d.). Phase 1 Study of first-in-class dUTPase inhibitor, TAS-114 in combination with capecitabine in patients with advanced solid tumors. European journal of cancer. pp. S119-. [Online].